HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Norimitsu Inoue Selected Research

Complement C6 (Complement 6)

8/2022Moyamoya Disease Associated with a Deficiency of Complement Component 6.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Norimitsu Inoue Research Topics

Disease

22Neoplasms (Cancer)
01/2022 - 12/2006
7Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria)
11/2020 - 04/2002
7Inflammation (Inflammations)
08/2020 - 06/2008
4Atypical Hemolytic Uremic Syndrome
12/2021 - 01/2019
4Hemolysis
12/2019 - 12/2002
3Infections
04/2021 - 06/2016
3Thrombotic Microangiopathies
01/2021 - 01/2019
3Squamous Cell Carcinoma of Head and Neck
08/2020 - 06/2017
2Thrombotic Thrombocytopenic Purpura
01/2019 - 01/2019
1Moyamoya Disease (Moya-Moya Disease)
08/2022
1Complement Component 6 Deficiency
08/2022
1Exanthema (Rash)
12/2021
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
12/2021
1Rare Diseases (Rare Disease)
12/2021
1Hemolytic Anemia
12/2021
1Thrombocytopenia (Thrombopenia)
12/2021
1Hereditary Complement Deficiency Diseases
04/2021
1Hemorrhage
01/2020
1Meningococcal Infections
01/2019
1Head and Neck Neoplasms (Head and Neck Cancer)
06/2017
1Acute-Phase Reaction
02/2017
1Hyperphosphatasia with Mental Retardation
03/2014
1Infantile Spasms (West Syndrome)
03/2014
1Epilepsy (Aura)
10/2013
1Hereditary Angioedemas
12/2012
1Autoimmune Diseases (Autoimmune Disease)
01/2011
1African Trypanosomiasis (Nagana)
09/2003
1Refractory Anemia
02/2003

Drug/Important Bio-Agent (IBA)

7Complement System Proteins (Complement)IBA
12/2021 - 12/2002
7Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA
11/2020 - 04/2002
6LigandsIBA
01/2022 - 06/2008
6Lactic Acid (Lactate)FDA LinkGeneric
08/2020 - 06/2008
5Proteins (Proteins, Gene)FDA Link
08/2022 - 04/2002
5Glucose (Dextrose)FDA LinkGeneric
08/2020 - 06/2008
5eculizumabFDA Link
01/2020 - 01/2019
4Toll-Like Receptors (Toll-Like Receptor)IBA
01/2022 - 07/2007
4CytokinesIBA
05/2018 - 10/2010
3Neoplasm Antigens (Tumor Antigens)IBA
01/2022 - 12/2014
2NucleotidesIBA
04/2021 - 01/2020
2Pharmaceutical PreparationsIBA
01/2020 - 06/2019
2Peptides (Polypeptides)IBA
01/2020 - 05/2018
2LipopeptidesIBA
05/2018 - 12/2014
2VaccinesIBA
05/2018 - 09/2010
2Immunologic Adjuvants (Immunologic Adjuvant)IBA
12/2014 - 07/2010
2Interleukin-23 (Interleukin 23)IBA
01/2011 - 06/2008
1Complement C6 (Complement 6)IBA
08/2022
1Liposomes (Liposome)IBA
01/2022
1AntigensIBA
01/2022
1PolymersIBA
01/2022
1AntibodiesIBA
12/2021
1Complement Factor H (Factor H)IBA
12/2021
1Complement C7 (Complement 7)IBA
04/2021
1Complement Factor B (Factor B)IBA
01/2021
1Biomarkers (Surrogate Marker)IBA
01/2021
1Fluorine-18IBA
08/2020
1Indicators and Reagents (Reagents)IBA
08/2020
1LipidsIBA
01/2020
1Oxygen (Dioxygen)IBA
01/2020
1Amino AcidsFDA Link
01/2020
1InflammasomesIBA
12/2019
1GPI-Linked ProteinsIBA
12/2019
1Factor V (Coagulation Factor V)IBA
06/2019
1Monoclonal AntibodiesIBA
06/2019
1Serine (L-Serine)FDA Link
05/2018
1Cancer VaccinesIBA
05/2018
1Toll-Like Receptor 2IBA
05/2018
1Lysine (L-Lysine)FDA Link
05/2018
1InterferonsIBA
05/2018
1Arginine (L-Arginine)FDA Link
05/2018
1Therapeutic UsesIBA
01/2017
1Interferon-gamma (Interferon, gamma)IBA
01/2017
1C-Reactive ProteinIBA
06/2016
1Immunoglobulin D (IgD)IBA
03/2014
1CD40 Ligand (CD40L)IBA
11/2013
1VitaminsIBA
10/2013
1Toll-Like Receptor 3IBA
02/2012
1IFIH1 Interferon-Induced HelicaseIBA
02/2012
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
02/2012
1Interleukin-6 (Interleukin 6)IBA
04/2011
1Interleukin-17 (Interleukin 17)IBA
01/2011
1Interleukin-12 (IL 12)IBA
10/2010
1Cell Wall SkeletonIBA
07/2010
1macrophage stimulatory lipopeptide 2IBA
07/2010
1Interleukin-23 Subunit p19IBA
06/2008
13' Untranslated Regions (3' UTR)IBA
12/2006
1Transcription Factors (Transcription Factor)IBA
12/2006
1COOH-terminal signal transamidaseIBA
09/2003
1HLA-DRB1 Chains (HLA DRB1)IBA
02/2003

Therapy/Procedure

9Immunotherapy
01/2022 - 07/2007
5Therapeutics
01/2022 - 12/2008
1Hematopoietic Stem Cell Transplantation
01/2021
1Laughter Therapy
01/2019